Genetic Testing and SDHx Mutations:

What do they have to do with PGL/GIST/Pheos?

This webcast highlights how SDHx mutations impact risks for paraganglioma, pheochromocytomas, and GIST, why genetic testing is helpful for any diagnosis of GIST, paraganglioma or pheochromocytoma, and what the SDHx genes have to do with tumor risk.
Also discussed: What types of tumors are associated with mutations in the SDHx genes, and how different SDHx genes (SDHA, SDHB, SDHC, SDHD, SDHAF2) have different tumor and location risks. This webcast will also give recommendations for screening and current research initiatives for SDHx and paragangliomas.

About the Presenter:

Samantha GreenbergSamantha Greenberg is a board-certified genetic counselor who oversees the SDHx clinic and specializes in paraganglioma research at Huntsman Cancer Institute. She graduated with a Master’s Degree in Human Genetics and a Master’s of Public Health from the University of Michigan, and a Bachelor’s Degree in neuroscience from the same university. Prior to her graduate training, she taught 7th grade science in Tulsa, Oklahoma, through Teach for America. At Huntsman, Samantha also continues public health genomics work with the Department of Health focused on rural clinician education and programming. She has worked to expand cancer genetics’ role in genitourinary cancers, and oversees the VHL Clinical Care Center.


We cannot provide individual medical advice during this webcast. Information provided in this webcast is not intended as a substitute for your physician’s guidance and care.